Leonard S. Schleifer, President & CEO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 14,228 shares at $710.04 ($10.1M) on 2022-04-06, disclosed to the SEC on 2022-04-07.
Open-market sale of $10.1M REGN by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $710.05 | 4,461 | $3.2M | 31.4% |
| 2 | $710.05 | 4,461 | $3.2M | 31.4% |
| 3 | $710.04 | 2,653 | $1.9M | 18.6% |
| 4 | $710.04 | 2,653 | $1.9M | 18.6% |
| Total | $710.05 avg | 14,228 | $10.1M | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-04 | $4.1M | — | Filing → |